UBS has given Nutrien a "Neutral" rating and set a target price of $51 per share.

Joshua Spector, an analyst at the Swiss bank, mentioned that Nutrien's performance in the third quarter was in line with expectations but slightly below consensus estimates.

The report noted that Nutrien's operating results were somewhat weak, although the company is making progress in managing costs and investments.

This evaluation comes as Nutrien continues to face challenges in the market while focusing on improving its operations.